@MaxMarsden83@eliance@sema Absolutely it is! Excellent presentation! Thanks for sharing how daily work is at the busiest trauma Center in 🇬🇧, high quality research and perfect implementation in your praxis! Missing all of you @teamaccu@IofPHC@HEMSRLH @RoyalLondonHosp 🩸♥️@SEMAeroespacial
@ResearchTim It’s difficult to beat the R&D department at BARTS. Always doing podium. Well done Team. World patients & families are infinitely thankful to great researchers. 💪🏻
https://t.co/AZHmK6lROS
In our recent study, awake prone position was associated with a significant improvement of oxygenation in COVID-19 patients with respiratory failure. (1/n) @PJZolfaghari @_alexfowler
#COVID-19 has required creating 2251 new ICU beds across the UK.
But the number of trained ICU staff hasn't risen to match.
Read our Recovery & Restitution statement about getting back to normal in a way that protects both patients & staff ▶️ https://t.co/3Dnl3ROcft
🚨We are recruiting!!
Links to a video 📽️showing a bit more about us
https://t.co/grVFl9swtq
To become a @NHSBartsHealth 🏥#covidwarrior ⬇️ B5: https://t.co/eJlnUmKugk
B6: https://t.co/K5oGmMc2Sp
Un informe científico español ha concluido que hay evidencia significativa sobre la transmisión del virus SARS-CoV-2 por aerosoles.
El informe aconseja actividades en exteriores y ventilar para reducir la transmisión por aerosoles.
➡️ https://t.co/w9hdCTzJYJ
This is hugely encouraging BUT it’d be important to understand whether vax prevents INFECTION (therefore transmission) or just SYMPTOMATIC DISEASE. Cold chain storage and distribution will also be a major challenge.
@drkateflavs you may need to explain what it does mean..day after day...hour after hour... Time after time..days and days...and who you do care for?...and why!! 1.000.000 RIP is not enough?@teamaccu@NHSBartsHealth
We can learn a lot about superspreader events from this new @NatureMedicine paper https://t.co/ouO7CyGXQE by @DillonCAdam @bencowling88@gmleunghku@hkumed
The Pareto 80/20 rule applied: 19% of infections were responsible for 80% of transmissions; 69% of cases did not transmit
#SARSCoV2 D614G Spike variant adopts conformations that make fusion more probable = more infectious. Good things: apparently no worse clinical outcome and equally immunogenic and susceptible to therapies (mAbs) that disrupt interaction with ACE2
We have some close competition going on this month! 💪😎 Infanta Leonor have randomised 4 patients so far, with @ChariteBerlin following very close behind with 3 patients randomised. With 14 days left of July, we wonder who will come out on top?! Watch this space. @germ_red